top of page
  • Recruiting
    • Dec 10, 2020

The clonoSEQ® Watch Registry

Updated: May 24, 2022

The clonoSEQ® Watch Registry


Real World Observational Study Using clonoSEQ® Next Generation Sequencing in Hematologic Malignancies: The 'Watch' Registry

clonoSEQ

This is a prospective, multicenter, observational study of adult patients with a diagnosis of acute lymphoblastic leukemia (ALL), multiple myeloma (MM), chronic lymphocytic leukemia (CLL), or non-Hodgkin lymphoma (NHL). This study will enroll up to 528 patients in up to 50 sites in the United States and collect data with regard to use of the clonoSEQ MRD assay in the management of lymphoid malignancies.


Diagnostic Test

clonoSEQ Assay


Sponsor

Adaptive Biotechnologies

 

ClinicalTrials.gov Identifier: NCT04545333


Official Title: Real World Observational Study Using clonoSEQ® Next Generation Sequencing in Hematologic Malignancies: The 'Watch' Registry


First Posted: September 11, 2020